4 Pharmaceutical Stocks to Buy Now

by Portfolio Grader | March 22, 2013 1:00 pm

4 Pharmaceutical Stocks to Buy Now

The grades of four Pharmaceutical stocks are better this week, according to the Portfolio Grader[1] database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

This week, Repros Therapeutics (NASDAQ:RPRX[2]) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. For more information, get Portfolio Grader’s complete analysis of RPRX stock[3].

This is a strong week for Johnson & Johnson (NYSE:JNJ[4]). The company’s rating climbs to A from the previous week’s B. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. At present, the stock has a dividend yield of 2.4%. For more information, get Portfolio Grader’s complete analysis of JNJ stock[5].

Bristol-Myers Squibb (NYSE:BMY[6]) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. The stock price has risen 8% over the past month, better than the 2.9% increase the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of BMY stock[7].

Watson Pharmaceuticals (NYSE:WPI[8]) is seeing ratings go up from a B last week to an A this week. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock[9].

Louis Navellier’s proprietary Portfolio Grader[10] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[11].

Endnotes:
  1. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  2. RPRX: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  3. For more information, get Portfolio Grader’s complete analysis of RPRX stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  4. JNJ: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  5. For more information, get Portfolio Grader’s complete analysis of JNJ stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  6. BMY: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  7. For more information, get Portfolio Grader’s complete analysis of BMY stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  8. WPI: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  9. For more information, get Portfolio Grader’s complete analysis of WPI stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  10. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  11. here: http://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: http://investorplace.com/2013/03/4-pharmaceutical-stocks-to-buy-now-rprx-jnj-bmy-4/
Short URL: http://invstplc.com/1nx6fa8